Search
for
Sort by
Research 271–300 of 1000+
- Brazilian pulmonology guidelines on Delphi panel for post-coronavirus disease 2019
- Can we halt male androgenetic alopecia progression without antiandrogenic drugs?
- Lysocellin, a metabolite of the novel drug ‘alopestatin’, induces G1 arrest and prevents cytotoxicity induced by etoposide
- Association between coronary artery disease and the diagonal earlobe and preauricular creases in men * Associação entre doença arterial coronariana e as pregas lobular diagonal e anterotragal em homens *
- Finasteride-Loaded Phospholipid-Bile Salt Mixed Micelles for Targeted Follicular Delivery in Androgenetic Alopecia.
- Monthly versus quarterly dutasteride mesotherapy for male androgenetic alopecia: A randomized trial
- Oral Minoxidil 2.5mg vs 5mg for Male Androgenetic Alopecia: A Double-Blind Randomized Clinical Trial.
- Response to “Improvement of female pattern hair loss with bicalutamide: a time-dependent process”
- Translation, cultural adaptation and validation of the Brazilian version of the Alopecia Areata Quality of Life Index (AA-QLI-BRA)
- Bicalutamide 25 mg associated with minoxidil 1 mg versus minoxidil 1 mg for female-pattern hair loss: A randomized double-blind clinical trial
- Sublingual Minoxidil 5 mg versus Oral Minoxidil 5 mg for male androgenetic alopecia: A double‐blind randomized clinical trial
- Effect of oral minoxidil 1 mg and 2.5 mg on the growth speed of hair and nails
- Prospective evaluation of blood pressure, heart rate, and side effects in hypertensive patients using low-dose oral minoxidil for hair loss
- Oral minoxidil 7.5 mg for hair loss increases heart rate with no change in blood pressure in 24 h Holter and 24 h ambulatory blood pressure monitoring
- Efficacy of 5% topical minoxidil versus 5 mg oral biotin versus topical minoxidil and oral biotin on hair growth in men: randomized, crossover, clinical trial
- Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia
- Skin of color repigmentation after phenol-croton oil chemical peel
- Profiling UK injectable aesthetic practitioners: A national cohort analysis
- Agaricus Subrufescens Ameliorates Ovarian Dysfunction and Regulates Altered Biochemical Parameters in Rats with Letrozole Induced Polycystic Ovarian Syndrome
- On the characterization of the effluvium following COVID‐19 infection
- Female pattern hair loss: therapeutic update
- Indicações, eficácia e efeitos colaterais do Minoxidil oral: revisão integrativa
- Development and Validation of a Dermoscopic Severity Score for Female Pattern Hair Loss
- JAAD – Prevalence of Female Pattern Hair Loss in a multiracial population (supplementary data)
- Adverse Effects of Low-dose Oral Minoxidil for Androgenetic Alopecia in 435 patients – Supplemental material
- Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
- Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome
- Plasma Rico em Plaquetas Otimizando o Rejuvenescimento Dérmico nos Procedimentos Estéticos
- DSP c.6310delA p.(Thr2104Glnfs*12) associates with arrhythmogenic cardiomyopathy, increased trabeculation, curly hair, and palmoplantar keratoderma
- Ultraviolet Radiation in Wound Care: Sterilization and Stimulation